Can’t Ignore: JD.com (NASDAQ:JD), Chesapeake Energy Corporation (NYSE:CHK), CEMEX, S.A.B. de C.V. (NYSE:CX), Eyegate Pharmaceuticals (NASDAQ:EYEG)

Morgan Stanley (NYSE:MS) ended the last trading day at $28.38. Company weekly volatility is calculated as 3.21% and price to cash ratio as 1.00. Morgan Stanley (NYSE:MS) showed a weekly performance of -10.78%.

Morgan Stanley (NYSE:MS) said that, it is working with the controlling private equity shareholder of ClearView Wealth to assess exit options, sources told Street Talk on Monday. Michael Alscher’s Crescent Capital Partners is understood to have selected Morgan Stanley to test the market’s appetite for a sale of the 53.6 per cent stake that it acquired in 2012.

JD.com, Inc. (NASDAQ:JD) ended the last trading day at $27.62. Company weekly volatility is calculated as 4.42% and price to cash ratio as 11.48. JD.com, Inc. (NASDAQ:JD) showed a weekly performance of -14.40%.

On 6 January, JD.com, Inc. (NASDAQ:JD) said that, HARMAN International Industries, Incorporated (NYSE:HAR), the premier connected technologies company for automotive, consumer and enterprise markets announced at the 2016 International Consumer Electronics Show in Las Vegas that it will enter into a strategic cooperation with JD.com (Nasdaq:JD), China’s largest direct online sales company. Chee Meng Koay, VP and GM, HARMAN Lifestyle Audio Division, Greater China, and Eric Wang, CEO of JD.com’s smart device platform and business unit JD Smart, announced the alliance.

On 08 January, Chesapeake Energy Corporation (NYSE:CHK) shares moved up 0.68% and was closed at $4.44. CHK EPS growth in last 5 year was 16.80%. Chesapeake Energy Corporation (NYSE:CHK) year to date (YTD) performance is -1.33%.

On 31 December, Chesapeake Energy Corporation (NYSE:CHK) announced the final results of its private offers to exchange (the “Exchange Offers”) new 8.00% Senior Secured Second Lien Notes due 2022 (the “Second Lien Notes”) for certain outstanding senior unsecured notes listed in the table below (the “Existing Notes”). As of 11:59 p.m., New York Citytime, on December 30, 2015 (the “Expiration Date”), approximately $3.8 billion aggregate principal amount, or approximately 41.5%, of Existing Notes had been validly tendered and not validly withdrawn.

CEMEX, S.A.B. de C.V. (NYSE:CX) shares decreased -6.91% in last trading session and ended the day at $4.31. CX Gross Margin is 33.30% and its has a return on assets of -1.00%. CEMEX, S.A.B. de C.V. (NYSE:CX) quarterly performance is -45.65%.

On 7 January, CEMEX, S.A.B. de C.V. (NYSE:CX) said that, a key element in the success of the Readymix business in 2015 was working with FORS to instigate a quality-management system which would help individual hauliers to achieve accreditation. This year work will continue with IHCs who operate in major conurbations outside London.

Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) caters to the Healthcare space. Its performance is -13.50%. On the last day of trading company shares ended up at $2.37. Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) distance from 50-day simple moving average (SMA50) is 1.34%.

Chardan Capital began coverage on shares of Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) in a research report released on Tuesday morning, Marketbeat.comreports. The brokerage issued a buy rating and a $6.00 target price on the specialty pharmaceutical company’s stock.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *